Patents by Inventor Massimo Broggini

Massimo Broggini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTITUMOR COMBINATION COMPRISING A MORPHOLINYL ANTHRACYCLINE DERIVATIVE AND DEMETHYLATING AGENTS
    Publication number: 20110021517
    Abstract: The present invention provides a combination of a morpholinyl anthracycline derivative, in particular a methoxy morpholino doxorubicin derivative, or a pharmaceutically acceptable salt thereof, and a demethylating agent, having an antineo-plastic effect. Also provided is the use of the said combinations in the treatment or prevention of metastasis, in the treatment of tumors, as well for reversing the resistance in cells resistant to such a methoxy morpholino doxorubicin derivative.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 27, 2011
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Maria Cristina Geroni, Olga Valota, Massimo Broggini
  • Oncosuppressive gene
    Patent number: 7189840
    Abstract: Isolation and characterization of an oncosuppressive gene which is involved in the apoptotic process and is regulated by p53 ad p73, polypeptide thereby encoded, sequences involved in gene regulation and genetic constructs thereof.
    Type: Grant
    Filed: July 9, 2002
    Date of Patent: March 13, 2007
    Assignee: Novuspharma S.p.A.
    Inventors: Massimo Broggini, Maurizio D'Incalci
  • Oncosupporessive gene
    Publication number: 20040259251
    Abstract: Isolation and characterization of an oncosuppressive gene which is involved in the apoptotic process and is regulated by p53 ad p73, polypeptide thereby encoded, sequences involved in gene regulation and genetic constructs thereof.
    Type: Application
    Filed: July 14, 2004
    Publication date: December 23, 2004
    Inventors: Massimo Broggini, Maurizio D'Incalci